Skip to Main Content

Illumina Inc

ILMN Real Time Price USD
N/A
N/A
N/A
...
...
Overview
Financials
Forecast
Insiders
Institutions
Government
Ownership
Income
Balance Sheet
Cash Flow
Revenue Breakdown

Recent trades of ILMN by members of U.S. Congress

Politician Type Traded
Michael C. Burgess House / R Sale $15,001 - $50,000 Sep. 03, 2024
Michael C. Burgess House / R Sale $15,001 - $50,000 Aug. 30, 2024
Thomas H. Kean, Jr. House / R Purchase $1,001 - $15,000 Apr. 19, 2024
Michael C. Burgess House / R Sale $1,001 - $15,000 Mar. 11, 2024
Michael C. Burgess House / R Sale $1,001 - $15,000 Mar. 11, 2024
Michael C. Burgess House / R Purchase $15,001 - $50,000 Feb. 12, 2024
Michael C. Burgess House / R Sale $1,001 - $15,000 Feb. 12, 2024
Michael C. Burgess House / R Sale $1,001 - $15,000 Feb. 12, 2024
Michael C. Burgess House / R Purchase $1,001 - $15,000 Jan. 02, 2024
Michael C. Burgess House / R Purchase $15,001 - $50,000 Jan. 02, 2024
Michael C. Burgess House / R Sale $1,001 - $15,000 Jan. 02, 2024
Kathy E. Manning House / D Sale $15,001 - $50,000 Jun. 10, 2022
Donald S. Beyer, Jr. House / D Sale $15,001 - $50,000 Feb. 28, 2022
Kathy E. Manning House / D Purchase $1,001 - $15,000 Dec. 01, 2021
Kathy E. Manning House / D Purchase $1,001 - $15,000 Oct. 26, 2021
Donald S. Beyer, Jr. House / D Sale $1,001 - $15,000 Sep. 17, 2021
Kathy E. Manning House / D Purchase $1,001 - $15,000 Aug. 25, 2021
Donald S. Beyer, Jr. House / D Sale $1,001 - $15,000 May. 06, 2021
Kathy E. Manning House / D Sale $1,001 - $15,000 Feb. 24, 2021
Donald S. Beyer, Jr. House / D Purchase $1,001 - $15,000 Nov. 17, 2020
Josh Gottheimer House / D Sale $1,001 - $15,000 Nov. 06, 2020
Donald S. Beyer, Jr. House / D Sale $1,001 - $15,000 Aug. 27, 2020
Donald S. Beyer, Jr. House / D Sale $1,001 - $15,000 Jul. 14, 2020
Donald S. Beyer, Jr. House / D Sale $1,001 - $15,000 May. 01, 2020
Donald S. Beyer, Jr. House / D Sale $1,001 - $15,000 Apr. 27, 2020
Sheldon Whitehouse Senate / D Sale (Full) $1,001 - $15,000 Mar. 11, 2020
Donald S. Beyer, Jr. House / D Purchase $1,001 - $15,000 Feb. 14, 2020
Donald S. Beyer, Jr. House / D Purchase $1,001 - $15,000 Jan. 27, 2020
Donald S. Beyer, Jr. House / D Purchase $1,001 - $15,000 Jan. 10, 2020
Donald S. Beyer, Jr. House / D Purchase $1,001 - $15,000 Dec. 23, 2019
John B. Larson House / D Sale $1,001 - $15,000 Dec. 18, 2019
Donald S. Beyer, Jr. House / D Purchase $1,001 - $15,000 Dec. 10, 2019
Donald S. Beyer, Jr. House / D Purchase $1,001 - $15,000 Nov. 25, 2019
Donald S. Beyer, Jr. House / D Purchase $1,001 - $15,000 Nov. 19, 2019
Josh Gottheimer House / D Sale $1,001 - $15,000 Sep. 11, 2019
Susan A. Davis House / D Purchase $15,001 - $50,000 Jan. 11, 2019
Sheldon Whitehouse Senate / D Purchase $1,001 - $15,000 Dec. 28, 2018
Josh Gottheimer House / D Purchase $1,001 - $15,000 Oct. 24, 2018
Josh Gottheimer House / D Sale $1,001 - $15,000 Jul. 24, 2017
K. Michael Conaway House / R Purchase $1,001 - $15,000 Feb. 09, 2015
Thomas MacArthur House / R Sale $1,001 - $15,000 Jan. 27, 2015
ILMN Stock Insider Trading Activity
Name
Type
Shares
Price
Shares Held
Date
Reported
ILMN Stock Institutional Owners
Investor
Shares
Change in Shares
Market Value
Date
Reported
ILMN Derivatives Institutional Owners
Investor
Type
Shares
Change in Shares
Market Value
Date
Reported

Recently reported changes by institutional investors

Quarterly net insider trading by ILMN's directors and management

Government lobbying spending instances

  • $400,000 Jan 21, 2025 Issue: Budget/Appropriations Health Issues Defense
  • $280,000 Dec 12, 2024 Issue: Budget/Appropriations Defense Health Issues
  • $270,000 Jul 22, 2024 Issue: Defense Trade (domestic/foreign) Health Issues
  • $380,000 Apr 22, 2024 Issue: Defense Trade (domestic/foreign) Health Issues
  • $510,000 Jan 22, 2024 Issue: Defense Trade (domestic/foreign) Government Issues Health Issues
  • $420,000 Oct 20, 2023 Issue: Defense Trade (domestic/foreign) Government Issues Health Issues
  • $1,460,000 Jul 20, 2023 Issue: Defense Trade (domestic/foreign) Government Issues Health Issues
  • $1,300,000 Jan 20, 2023 Issue: Trade (domestic/foreign) Government Issues Health Issues
  • $1,380,000 Oct 20, 2022 Issue: Trade (domestic/foreign) Government Issues Health Issues
  • $1,690,000 Jul 20, 2022 Issue: Trade (domestic/foreign) Government Issues Health Issues
  • $1,960,000 Apr 20, 2022 Issue: Government Issues Health Issues
  • $820,000 Jan 20, 2022 Issue: Government Issues
  • $10,000 Jan 20, 2022 Issue: Government Issues
  • $60,000 Jan 20, 2022 Issue: Health Issues
  • $50,000 Jan 20, 2022 Issue: None
  • $40,000 Jan 20, 2022 Issue: Labor Issues/Antitrust/Workplace Medicare/Medicaid Health Issues
  • $50,000 Jan 20, 2022 Issue: Health Issues
  • $60,000 Jan 19, 2022 Issue: Health Issues
  • $320,000 Jan 19, 2022 Issue: Health Issues Government Issues
  • $10,000 Oct 28, 2021 Issue: Government Issues
  • $920,000 Oct 21, 2021 Issue: Government Issues
  • $60,000 Oct 20, 2021 Issue: Health Issues
  • $50,000 Oct 20, 2021 Issue: None
  • $40,000 Oct 20, 2021 Issue: Medicare/Medicaid Health Issues Labor Issues/Antitrust/Workplace
  • $10,000 Oct 19, 2021 Issue: Government Issues
  • $50,000 Oct 19, 2021 Issue: Health Issues
  • $375,000 Oct 18, 2021 Issue: Health Issues Government Issues
  • $20,000 Jul 29, 2021 Issue: Health Issues
  • $60,000 Jul 20, 2021 Issue: Health Issues Labor Issues/Antitrust/Workplace
  • $40,000 Jul 20, 2021 Issue: Labor Issues/Antitrust/Workplace Health Issues Veterans Medicare/Medicaid
  • $40,000 Jul 20, 2021 Issue: Government Issues
  • $150,000 Jul 19, 2021 Issue: Health Issues Government Issues
  • $50,000 Jul 19, 2021 Issue: Trade (domestic/foreign)
  • $290,000 Apr 20, 2021 Issue: None
  • $270,000 Jan 21, 2021 Issue: None
  • $270,000 Oct 20, 2020 Issue: None
  • $170,000 Jul 20, 2020 Issue: None
  • $180,000 Apr 20, 2020 Issue: HEALTH ISSUES
  • $190,000 Jan 21, 2020 Issue: None
  • $160,000 Oct 21, 2019 Issue: Budget/Appropriations Health Issues
  • $160,000 Jul 22, 2019 Issue: Budget/Appropriations Health Issues
  • $130,000 Apr 22, 2019 Issue: Health Issues Budget/Appropriations
  • $60,000 Jan 22, 2019 Issue: Health Issues
  • $60,000 Oct 22, 2018 Issue: Health Issues
  • $70,000 Jul 20, 2018 Issue: Health Issues
  • $100,000 Apr 20, 2018 Issue: Medicare/Medicaid Budget/Appropriations
  • $50,000 Jan 19, 2018 Issue: Medical/Disease Research/Clinical Labs Medicare/Medicaid Budget/Appropriations
  • $50,000 Oct 20, 2017 Issue: Medical/Disease Research/Clinical Labs Medicare/Medicaid Budget/Appropriations
  • $50,000 Jul 20, 2017 Issue: Medical/Disease Research/Clinical Labs Budget/Appropriations Medicare/Medicaid
  • $40,000 Apr 18, 2017 Issue: Medical/Disease Research/Clinical Labs
  • $45,000 Jan 13, 2017 Issue: Health Issues
  • $45,000 Oct 19, 2016 Issue: Health Issues
  • $60,000 Jul 20, 2016 Issue: Health Issues
  • $90,000 Apr 20, 2016 Issue: Health Issues
  • $20,000 Jan 20, 2016 Issue: Health Issues
  • $40,000 Jan 18, 2013 Issue: Homeland Security Science/Technology Defense

Estimated quarterly lobbying spending

ILMN Revenue by Segment or Geography

By Segment
By Geography
Quiver Logo

No Revenue by Segment data for this ticker

Revenue Breakdown Dashboard
Quiver Logo

No Revenue by Geography data for this ticker

Revenue Breakdown Dashboard
ILMN Income Statement
ILMN Balance Sheet
ILMN Cash Flow
U.S. Patents

New patents grants

  • Patent Title: Compositions and methods for improving sample identification in indexed nucleic acid libraries Mar. 11, 2025
  • Patent Title: Sensors having integrated protection circuitry Mar. 04, 2025
  • Patent Title: Multiplexing of an active sensor detector using structured illumination Mar. 04, 2025
  • Patent Title: Tiered ligation oligos Mar. 04, 2025
  • Patent Title: Temperature-controllable reagent cartridge and temperature control system for the same Mar. 04, 2025
  • Patent Title: Flow cell with enhanced well imaging resolution Mar. 04, 2025
  • Patent Title: Reagent cartridge Mar. 04, 2025
  • Patent Title: Temporary cloud provider credentials via secure discovery framework Feb. 25, 2025
  • Patent Title: Base calling using convolution Feb. 25, 2025
  • Patent Title: Tagmentation using immobilized transposomes with linkers Feb. 25, 2025
  • Patent Title: Tube strip Feb. 25, 2025
  • Patent Title: Systems and methods for grouping and collapsing sequencing reads Feb. 18, 2025
  • Patent Title: Sequencing instrument Oct. 29, 2024
  • Patent Title: Sequencing instrument Oct. 29, 2024
  • Patent Title: Detector with reduced fluorescence range noise Oct. 22, 2024
  • Patent Title: Deep neural network-based sequencing Oct. 15, 2024
  • Patent Title: Waveguide integration with optical coupling structures on light detection device Oct. 08, 2024
  • Patent Title: Selective surface patterning via nanoimprinting Oct. 08, 2024
  • Patent Title: Thermostable terminal deoxynucleotidyl transferase Oct. 08, 2024
  • Patent Title: Modified polymerases for improved incorporation of nucleotide analogues Oct. 08, 2024
  • Patent Title: Artificial intelligence-based many-to-many base calling Oct. 01, 2024
  • Patent Title: Systems and devices for signal corrections in pixel-based sequencing Oct. 01, 2024
  • Patent Title: Analysis of multiple analytes using a single assay Oct. 01, 2024
  • Patent Title: Polymerases, compositions, and methods of use Oct. 01, 2024
  • Patent Title: Image sensor structure with a light guide layer and a nanowell layer Sep. 24, 2024
  • Patent Title: Optical distortion correction for imaged samples Sep. 24, 2024
  • Patent Title: Flowcell cartridge with floating seal bracket Sep. 24, 2024
  • Patent Title: Cartridge component Sep. 24, 2024
  • Patent Title: Vial assembly Sep. 17, 2024
  • Patent Title: Sequencing instrument Sep. 17, 2024
  • Patent Title: Image sensor structure Sep. 10, 2024
  • Patent Title: Using cell-free dna fragment size to detect tumor-associated variant Sep. 10, 2024
  • Patent Title: Flow cells Sep. 10, 2024
  • Patent Title: Compositions and methods for chemical cleavage and deprotection of surface-bound oligonucleotides Sep. 10, 2024
  • Patent Title: Interposer with first and second adhesive layers Sep. 10, 2024
  • Patent Title: Quality score compression Sep. 03, 2024
  • Patent Title: Polymerases, compositions, and methods of use Sep. 03, 2024
  • Patent Title: Fluidic device and method for preparing a sample substrate Sep. 03, 2024
  • Patent Title: Deep learning-based framework for identifying sequence patterns that cause sequence-specific errors (sses) Aug. 27, 2024
  • Patent Title: Reagent mixing system and methods Aug. 27, 2024
  • Patent Title: Laminate fluidic circuit for a fluid cartridge Aug. 27, 2024
  • Patent Title: Valve assemblies and related systems Aug. 27, 2024
  • Patent Title: Polynucleotide amplification using crispr-cas systems Aug. 20, 2024
  • Patent Title: Fixtures and related systems and methods Aug. 20, 2024
  • Patent Title: Flow cell with flexible connection Aug. 20, 2024
  • Patent Title: Apparatus and methods for transmitting light Aug. 13, 2024
  • Patent Title: Sensors having an active surface Aug. 13, 2024
  • Patent Title: Storage device, system, and method Aug. 13, 2024
  • Patent Title: Polymer coatings Aug. 13, 2024
  • Patent Title: Method for selecting and amplifying polynucleotides Aug. 13, 2024
Government Contracts

Federal grants, loans, and purchases

Government Contracts

Estimated quarterly amount awarded from public contracts

ILMN News

Recent insights relating to ILMN

WallStreetBets

Number of mentions of ILMN in WallStreetBets Daily Discussion

CNBC Recommendations

Recent picks made for ILMN stock on CNBC

Top ETF Holders

ETFs with the largest estimated holdings in ILMN

ILMN Analyst Ratings

ILMN Stock Forecasts
...

  • ... Highest Price Target
  • ... Median Price Target
  • ... Lowest Price Target
ILMN Analyst Forecasts
Analyst
Firm
Current
Previous
Date
Frequently Asked Questions
  • Is $ILMN stock a Buy, Sell, or Hold?

  • What is the price target for $ILMN stock?

* Analyst consensus is not financial advice. Please see our data disclaimers .

ILMN Top Shareholders
Shareholder
Shares Held
ILMN Options Owners
Shareholder
Security
Underlying Shares
Frequently Asked Questions
  • Who owns $ILMN stock?

  • Who owns the most shares of $ILMN stock?

  • What funds own $ILMN stock?

* These are estimates based on data taken from SEC filings. There may be inaccuracies due to parsing errors, accidental double-counting, incorrect classification of indirectly owned shares, or any other number of issues.

ILMN Stock Smart Score

The Quiver Smart Score combines our data on Congress Trading, Lobbying, Insider Trading, CNBC Mentions and more to provide a comprehensive view of the strength of a stock's underlying data.

The Smart Score grades stocks on a scale of 1 (weakest) to 10 (strongest) based on the strength of the underlying data.
?

Sign Up to view ILMN Smart Score

Score Breakdown
Bull Case vs Bear Case

See concise summaries of analyst reports, presenting both bullish and bearish arguments for a stock.

Example:

Bulls Say:

The Bulls Say summary highlights positive aspects of the stock.

Bears Say:

The Bears Say summary points out potential risks and negative aspects of the stock.

Show More
Back To Top